OLD National Bancorp IN Invests $218,000 in ICU Medical, Inc. (NASDAQ:ICUI)

OLD National Bancorp IN bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,198 shares of the medical instruments supplier’s stock, valued at approximately $218,000.

Several other institutional investors and hedge funds have also made changes to their positions in ICUI. Xponance Inc. increased its stake in shares of ICU Medical by 6.0% during the second quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock valued at $235,000 after buying an additional 112 shares during the period. CWM LLC increased its stake in shares of ICU Medical by 18.5% during the second quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock valued at $91,000 after buying an additional 120 shares during the period. Hexagon Capital Partners LLC increased its stake in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 122 shares during the period. GAMMA Investing LLC increased its stake in shares of ICU Medical by 75.1% during the first quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 133 shares during the period. Finally, Russell Investments Group Ltd. increased its stake in shares of ICU Medical by 46.4% during the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 173 shares during the period. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Price Performance

ICUI opened at $177.70 on Thursday. The business’s 50-day moving average is $171.90 and its two-hundred day moving average is $133.88. ICU Medical, Inc. has a 1 year low of $78.28 and a 1 year high of $188.53. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.41 and a quick ratio of 1.08. The firm has a market capitalization of $4.33 billion, a PE ratio of -72.53 and a beta of 0.66.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.56. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. The business had revenue of $596.50 million for the quarter, compared to analyst estimates of $556.64 million. During the same quarter in the previous year, the firm earned $1.58 earnings per share. The company’s revenue was up 8.6% on a year-over-year basis. Research analysts anticipate that ICU Medical, Inc. will post 3.76 earnings per share for the current fiscal year.

Insider Transactions at ICU Medical

In other news, VP Daniel Woolson sold 2,502 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the sale, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares of the company’s stock, valued at $2,139,324.54. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $156.04, for a total value of $1,872,480.00. Following the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,320,691.72. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 40,552 shares of company stock worth $6,679,322. Insiders own 6.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ICUI. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Thursday, October 10th. Jefferies Financial Group began coverage on ICU Medical in a research note on Monday, October 14th. They set a “hold” rating and a $183.00 price target on the stock. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Thursday, September 12th. KeyCorp lifted their target price on ICU Medical from $147.00 to $198.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Finally, Raymond James lifted their target price on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $170.25.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.